March 6th Options Now Available For UiPath (PATH)

UiPath (PATH) is the subject of two options strategies presented by Stock Options Channel: a sell-to-open $13.50 put (current bid $0.58) which would result in an effective share cost basis of $12.92 versus the current stock price of $14.68 and has a 66% probability of expiring worthless; that premium equates to a 4.30% return (36.47% annualized). On the call side, selling a $15.50 covered call (bid $0.76) against $14.68 shares would yield a 10.76% total return if called at the March 6 expiration, with a 49% chance of expiring worthless and a 5.18% premium boost (43.95% annualized). Implied volatilities are 116% for the put and 68% for the call versus a trailing 12‑month volatility of 61%.

Analysis

Market structure: The option chain shows asymmetric risk pricing — 116% IV on the $13.50 put vs 68% IV on the $15.50 call with stock trading $14.68, signaling a pronounced downside skew and demand for protection. Short-term option sellers and market-makers collecting premium benefit if no shock occurs; long-equity holders face capped upside if they write calls. This implies supply of downside insurance > demand for upside speculation, concentrating gamma risk in dealers and amplifying moves on news over the next ~6 weeks to March 6 expiry.

Risk assessment: Tail risks include a negative earnings/guidance surprise, customer churn in automation demand, or an IV spike that pushes PATH below $11–12 and forces assignment or painful hedging; probability of put expiring worthless is ~66% but binary loss if adverse move occurs. Immediate (days–weeks): option decay dominates P/L; short-term (weeks–months): catalytic guidance/earnings; long-term (quarters+): adoption and margin expansion drive valuation. Hidden dependency: the high put IV indicates concentrated short-protection buying that could unwind violently if macro risk reprices.

Trade implications: For tactical income, use defined-risk sells (sell $13.50/$11 Mar 6 put spread) instead of naked puts to cap downside; covered-call sellers can harvest the $0.76 on $15.50 strike but accept 10.8% to-expiry cap. For directional views, prefer buy-call spreads if you expect a positive catalyst (14–17 Mar call spread) because call IV is cheaper; if neutral, harvest premium with small position sizing (1–3% notional) and strict stop-loss triggers.

Contrarian angles: Consensus sees cheapness to enter via puts, but skew may be overstated if no company-specific shock arrives — IV could collapse 30–50% post-catalyst, creating large mark-to-market gains for sellers. Conversely, placing naked exposure underestimates assignment risk and funding/margin impacts. Historical parallel: small-cap SaaS with elevated put skew often mean-reverts after a clean print; if PATH posts stable ARR growth, short-term sellers will pocket outsized realized vol vs implied.

Key Decisions for Investors

• Sell-to-open PATH Mar 6 $13.50/$11.00 put spread (defined-risk) sized to <=2% portfolio exposure; target credit such that max loss equals width minus credit; close if PATH < $12.00 or credit value compresses by 50% (likely within 1–3 weeks).
• If already long PATH, sell Mar 6 $15.50 covered calls (collect $0.76) to lock a pre-expiry total return of ~10.8%; roll or buy back if PATH > $16.50 or if IV rises >20% from current levels.
• Do NOT sell naked $13.50 puts larger than allocation above; instead allocate residual risk budget to buying a cheap directional call spread (buy Mar 6 $14/$17 call spread) if expecting positive guidance, size <=1% portfolio, take profits if spread doubles or PATH > $17.
• Implement a pair hedge for idiosyncratic risk: long PATH (or assigned via spread) and short equivalent beta of the iShares Expanded Tech-Software ETF (IGV) sized to neutralize market beta over 3–6 months; rebalance monthly and unwind if PATH outperforms IGV by >15%.